ResearcherBeckman Research InstituteNo recent work listed
Keisuke Okuno
Matched on ORCID iD 0009-0009-6964-2726; OpenAlex author ID A5083389433. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2022: 1 paper · 2023: 2 papers
Papers 3
- Intratumoral Malasseziaglobosa Levels Predict Survival and Therapeutic Response to Adjuvant Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2023.04.017↗
- Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/biomedicines11010119↗
- Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ph15101199↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ajay Goel · 3 shared papers, 2022–2023 · strength 0.53
- Paper Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Du… DOI 10.3390/biomedicines11010119↗
- Paper Intratumoral Malasseziaglobosa Levels Predict Survival and Therapeutic Response to Adjuvant Chemotherapy in Patients Wi… DOI 10.1053/j.gastro.2023.04.017↗
- Paper Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic … DOI 10.3390/ph15101199↗
- Caiming Xu · 2 shared papers, 2022–2023 · strength 0.35
- Paper Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Du… DOI 10.3390/biomedicines11010119↗
- Paper Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic … DOI 10.3390/ph15101199↗
- Cristina Fillat Fonts · 2 shared papers, 2022–2023 · strength 0.35
- Paper Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Du… DOI 10.3390/biomedicines11010119↗
- Paper Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic … DOI 10.3390/ph15101199↗
- Silvia Pascual-Sabater · 2 shared papers, 2022–2023 · strength 0.35
- Paper Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Du… DOI 10.3390/biomedicines11010119↗
- Paper Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic … DOI 10.3390/ph15101199↗
- Haiyong Han · 2 shared papers, 2022–2023 · strength 0.35
- Paper Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Du… DOI 10.3390/biomedicines11010119↗
- Paper Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic … DOI 10.3390/ph15101199↗
- Tetsuji Takayama · 1 shared paper, 2023 · strength 0.18
- Mitsuro Kanda · 1 shared paper, 2023 · strength 0.18
- Hideo Baba · 1 shared paper, 2023 · strength 0.18
- Yasuhide Yamada · 1 shared paper, 2023 · strength 0.18
- Yasuhiro Kodera · 1 shared paper, 2023 · strength 0.18
- Daniel D. Von Hoff · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.